![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ZBTB7A |
Gene summary for ZBTB7A |
![]() |
Gene information | Species | Human | Gene symbol | ZBTB7A | Gene ID | 51341 |
Gene name | zinc finger and BTB domain containing 7A | |
Gene Alias | FBI-1 | |
Cytomap | 19p13.3 | |
Gene Type | protein-coding | GO ID | GO:0000122 | UniProtAcc | O95365 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
51341 | ZBTB7A | HTA11_3410_2000001011 | Human | Colorectum | AD | 2.82e-06 | -4.15e-01 | 0.0155 |
51341 | ZBTB7A | HTA11_347_2000001011 | Human | Colorectum | AD | 2.03e-18 | 6.56e-01 | -0.1954 |
51341 | ZBTB7A | HTA11_411_2000001011 | Human | Colorectum | SER | 7.02e-03 | 7.51e-01 | -0.2602 |
51341 | ZBTB7A | HTA11_83_2000001011 | Human | Colorectum | SER | 6.42e-06 | 6.01e-01 | -0.1526 |
51341 | ZBTB7A | HTA11_696_2000001011 | Human | Colorectum | AD | 1.91e-06 | 4.91e-01 | -0.1464 |
51341 | ZBTB7A | HTA11_1391_2000001011 | Human | Colorectum | AD | 1.58e-04 | 5.56e-01 | -0.059 |
51341 | ZBTB7A | HTA11_99999970781_79442 | Human | Colorectum | MSS | 4.44e-05 | -3.69e-01 | 0.294 |
51341 | ZBTB7A | A002-C-010 | Human | Colorectum | FAP | 8.87e-06 | -3.40e-01 | 0.242 |
51341 | ZBTB7A | A015-C-203 | Human | Colorectum | FAP | 1.20e-24 | -2.58e-01 | -0.1294 |
51341 | ZBTB7A | A002-C-201 | Human | Colorectum | FAP | 1.52e-07 | -8.98e-02 | 0.0324 |
51341 | ZBTB7A | A002-C-203 | Human | Colorectum | FAP | 8.04e-06 | -1.54e-01 | 0.2786 |
51341 | ZBTB7A | A001-C-108 | Human | Colorectum | FAP | 1.79e-12 | -1.26e-01 | -0.0272 |
51341 | ZBTB7A | A002-C-205 | Human | Colorectum | FAP | 2.46e-15 | -2.90e-01 | -0.1236 |
51341 | ZBTB7A | A001-C-104 | Human | Colorectum | FAP | 6.73e-03 | -2.29e-01 | 0.0184 |
51341 | ZBTB7A | A015-C-005 | Human | Colorectum | FAP | 4.48e-02 | -1.76e-01 | -0.0336 |
51341 | ZBTB7A | A015-C-006 | Human | Colorectum | FAP | 1.27e-10 | -2.72e-02 | -0.0994 |
51341 | ZBTB7A | A015-C-106 | Human | Colorectum | FAP | 4.99e-08 | -2.24e-01 | -0.0511 |
51341 | ZBTB7A | A002-C-114 | Human | Colorectum | FAP | 3.92e-12 | -2.61e-02 | -0.1561 |
51341 | ZBTB7A | A015-C-104 | Human | Colorectum | FAP | 1.06e-25 | -2.57e-01 | -0.1899 |
51341 | ZBTB7A | A001-C-014 | Human | Colorectum | FAP | 1.95e-12 | -2.05e-01 | 0.0135 |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:004340115 | Prostate | Tumor | steroid hormone mediated signaling pathway | 48/3246 | 136/18723 | 3.53e-07 | 7.87e-06 | 48 |
GO:000913518 | Prostate | Tumor | purine nucleoside diphosphate metabolic process | 39/3246 | 103/18723 | 5.60e-07 | 1.19e-05 | 39 |
GO:000917918 | Prostate | Tumor | purine ribonucleoside diphosphate metabolic process | 39/3246 | 103/18723 | 5.60e-07 | 1.19e-05 | 39 |
GO:007155915 | Prostate | Tumor | response to transforming growth factor beta | 76/3246 | 256/18723 | 6.86e-07 | 1.40e-05 | 76 |
GO:004544414 | Prostate | Tumor | fat cell differentiation | 69/3246 | 229/18723 | 1.22e-06 | 2.28e-05 | 69 |
GO:20006771 | Prostate | Tumor | regulation of transcription regulatory region DNA binding | 23/3246 | 50/18723 | 2.48e-06 | 4.19e-05 | 23 |
GO:004693916 | Prostate | Tumor | nucleotide phosphorylation | 37/3246 | 101/18723 | 2.73e-06 | 4.54e-05 | 37 |
GO:007156015 | Prostate | Tumor | cellular response to transforming growth factor beta stimulus | 72/3246 | 250/18723 | 4.47e-06 | 7.02e-05 | 72 |
GO:004346715 | Prostate | Tumor | regulation of generation of precursor metabolites and energy | 43/3246 | 130/18723 | 9.55e-06 | 1.39e-04 | 43 |
GO:000616516 | Prostate | Tumor | nucleoside diphosphate phosphorylation | 35/3246 | 99/18723 | 1.25e-05 | 1.76e-04 | 35 |
GO:000609617 | Prostate | Tumor | glycolytic process | 30/3246 | 81/18723 | 1.82e-05 | 2.41e-04 | 30 |
GO:000632514 | Prostate | Tumor | chromatin organization | 104/3246 | 409/18723 | 2.02e-05 | 2.62e-04 | 104 |
GO:000717915 | Prostate | Tumor | transforming growth factor beta receptor signaling pathway | 58/3246 | 198/18723 | 2.11e-05 | 2.72e-04 | 58 |
GO:003314313 | Prostate | Tumor | regulation of intracellular steroid hormone receptor signaling pathway | 28/3246 | 74/18723 | 2.16e-05 | 2.77e-04 | 28 |
GO:000675717 | Prostate | Tumor | ATP generation from ADP | 30/3246 | 82/18723 | 2.39e-05 | 3.00e-04 | 30 |
GO:000975514 | Prostate | Tumor | hormone-mediated signaling pathway | 56/3246 | 190/18723 | 2.39e-05 | 3.00e-04 | 56 |
GO:004603116 | Prostate | Tumor | ADP metabolic process | 32/3246 | 90/18723 | 2.53e-05 | 3.14e-04 | 32 |
GO:000911718 | Prostate | Tumor | nucleotide metabolic process | 120/3246 | 489/18723 | 2.81e-05 | 3.41e-04 | 120 |
GO:000675317 | Prostate | Tumor | nucleoside phosphate metabolic process | 121/3246 | 497/18723 | 3.81e-05 | 4.41e-04 | 121 |
GO:003314412 | Prostate | Tumor | negative regulation of intracellular steroid hormone receptor signaling pathway | 17/3246 | 38/18723 | 7.85e-05 | 8.14e-04 | 17 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
ZBTB7A | MLUM | Breast | DCIS | MALAT1,DDX5,PPDPF, etc. | 6.46e-01 | ![]() |
ZBTB7A | BN | Liver | HCC | RNF166,PPP3R1,XPC, etc. | 4.84e-02 | ![]() |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ZBTB7A | SNV | Missense_Mutation | novel | c.1125N>T | p.Lys375Asn | p.K375N | O95365 | protein_coding | deleterious(0) | probably_damaging(0.973) | TCGA-GM-A2DD-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | fluorouracil | CR |
ZBTB7A | SNV | Missense_Mutation | rs753845110 | c.1684N>A | p.Gly562Ser | p.G562S | O95365 | protein_coding | tolerated_low_confidence(0.71) | benign(0.001) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
ZBTB7A | SNV | Missense_Mutation | novel | c.1435N>A | p.Asp479Asn | p.D479N | O95365 | protein_coding | deleterious(0) | possibly_damaging(0.872) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
ZBTB7A | SNV | Missense_Mutation | novel | c.700N>A | p.Gly234Arg | p.G234R | O95365 | protein_coding | tolerated(0.18) | possibly_damaging(0.502) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
ZBTB7A | insertion | Frame_Shift_Ins | rs749935719 | c.522dupC | p.Ala175ArgfsTer19 | p.A175Rfs*19 | O95365 | protein_coding | TCGA-EA-A6QX-01 | Cervix | cervical & endocervical cancer | Female | <65 | III/IV | Unknown | Unknown | SD | ||
ZBTB7A | SNV | Missense_Mutation | c.1217N>T | p.Gly406Val | p.G406V | O95365 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-AA-3866-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
ZBTB7A | SNV | Missense_Mutation | novel | c.1211A>G | p.His404Arg | p.H404R | O95365 | protein_coding | deleterious(0.01) | probably_damaging(0.975) | TCGA-AA-3984-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
ZBTB7A | SNV | Missense_Mutation | novel | c.1220A>T | p.Glu407Val | p.E407V | O95365 | protein_coding | deleterious(0) | probably_damaging(0.976) | TCGA-AA-A022-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
ZBTB7A | SNV | Missense_Mutation | c.469N>A | p.Ala157Thr | p.A157T | O95365 | protein_coding | deleterious(0.03) | possibly_damaging(0.713) | TCGA-CK-4951-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
ZBTB7A | SNV | Missense_Mutation | c.28N>A | p.Gly10Arg | p.G10R | O95365 | protein_coding | deleterious(0) | probably_damaging(0.989) | TCGA-CM-4744-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |